Global Cord Blood Corp
OTC:CORBF

Watchlist Manager
Global Cord Blood Corp Logo
Global Cord Blood Corp
OTC:CORBF
Watchlist
Price: 0.95 USD
Market Cap: $127.2m

Wall Street
Price Targets

CORBF Price Targets Summary
Global Cord Blood Corp

There are no price targets for CORBF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Global Cord Blood Corp Competitors:
Price Targets
TNDM
Tandem Diabetes Care Inc
52% Upside
BMRN
Biomarin Pharmaceutical Inc
66% Upside
PHVS
Pharvaris NV
61% Upside
CNC
Concurrent Technologies PLC
28% Upside

Revenue
Forecast

10% / Year
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
10% / Year
Past Growth
-41% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for Global Cord Blood Corp's revenue is 10%. The projected CAGR for the next 4 years is -41%.

Operating Income
Forecast

13% / Year
Past Growth
-46% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
13% / Year
Past Growth
-46% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for Global Cord Blood Corp's operating income is 13%. The projected CAGR for the next 4 years is -46%.

Net Income
Forecast

20% / Year
Past Growth
-40% / Year
Estimated Growth
Estimates Accuracy
N/A
Average
20% / Year
Past Growth
-40% / Year
Estimated Growth
Estimates Accuracy
N/A
Average

For the last 8 years the compound annual growth rate for Global Cord Blood Corp's net income is 20%. The projected CAGR for the next 4 years is -40%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CORBF's stock price target?
Not Available

CORBF doesn't have any price targets made by Wall Street professionals.

What is Global Cord Blood Corp's Revenue forecast?
Projected CAGR
-41%

For the last 8 years the compound annual growth rate for Global Cord Blood Corp's revenue is 10%. The projected CAGR for the next 4 years is -41%.

What is Global Cord Blood Corp's Operating Income forecast?
Projected CAGR
-46%

For the last 8 years the compound annual growth rate for Global Cord Blood Corp's operating income is 13%. The projected CAGR for the next 4 years is -46%.

What is Global Cord Blood Corp's Net Income forecast?
Projected CAGR
-40%

For the last 8 years the compound annual growth rate for Global Cord Blood Corp's net income is 20%. The projected CAGR for the next 4 years is -40%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett